Posted by Ethan Ryder on Feb 6th, 2026
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) CEO Christopher Peetz sold 9,108 shares of the stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $103.30, for a total transaction...
More of this article »